UBS Group

UBS Group’s Silexion Therapeutics SLXN Stock Holding History

UBS Group’s Portfolio SLXN Stock Details SLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$88.5K	Buy
2025 Q1	$80.2K	Buy
2024 Q4	$29.9K	Buy
2024 Q3	$7.91K	Buy